EUVIMEDEUVIMED entdecken
EditorialOpen Access

Beyond muscle: could GLP-1 receptor agonists offset the tendon risk of intensive lipid-lowering therapy?

Yashendra Sethi, Kunal Mahajan, Maciej Banach

Archives of Medical Science · 03.08.2026

DOI: 10.5114/aoms/226714 ↗

Kurz gefasst

Editorial in der Zeitschrift Archives of Medical Science, online erschienen am 03.08.2026. Verfasst von Yashendra Sethi und 2 weiteren Autor:innen. Beteiligte Einrichtung: PearResearch, Dehradun, India. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tendinopathy and tendon rupture occupy an odd position in cardiovascular (CV) medicine: formally recognised as adverse events of special interest (AESI) in contemporary lipid trials, and routinely adjudicated within them, yet almost never discussed at cardiology meetings.The systematic review and meta-analysis by Khayyat and Khayyat in the current 4/2026 issue of Archives of Medical Science [1] approaches the tendon from the opposite direction, asking whether glucagon-like peptide-1 receptor agonists (GLP-1RAs) promote its healing.Their answer is cautious, and appropriately so.The question their work opens is considerably larger, and it belongs to lipidology. What the meta-analysis establishes, and where it stopsThe authors screened 773 records and synthesized 41.Of six retrospective cohorts, only two -both in total shoulder arthroplasty -proved poolable, yielding an odds ratio for revision of 0.71 (95% CI: 0.59-0.85)with I² = 0% [1].The estimate is statistically tidy and evidentially thin: two administrative database analyses, standing alongside a

Autor:innen und Institutionen

  • PearResearch, Dehradun, India.
  • Department of Cardiometabolic Medicine, Nobilis Institute of Cardiometabolic Excellence (NICE), Vigyaved Healthcare, Dehradun, India.
  • Department of Medicine, Subharti Medical College, Swami Vivekanand Subharti University, Meerut, India.
  • Department of Cardiology, Himachal Heart Institute, Mandi, Himachal Pradesh, India.
  • Department of Preventive Cardiology and Lipidology, Medical University of Lodz (MUL), Lodz, Poland.

Zitieren

APA

Sethi, Y., Mahajan, K., & Banach, M. (2026). Beyond muscle: could GLP-1 receptor agonists offset the tendon risk of intensive lipid-lowering therapy?. Archives of Medical Science. https://doi.org/10.5114/aoms/226714

Vancouver

Sethi Y, Mahajan K, Banach M. Beyond muscle: could GLP-1 receptor agonists offset the tendon risk of intensive lipid-lowering therapy?. Archives of Medical Science. 2026. doi:10.5114/aoms/226714

BibTeX
@article{Sethi2026,
  author = {Sethi, Yashendra and Mahajan, Kunal and Banach, Maciej},
  title = {Beyond muscle: could GLP-1 receptor agonists offset the tendon risk of intensive lipid-lowering therapy?},
  journal = {Archives of Medical Science},
  year = {2026},
  doi = {10.5114/aoms/226714}
}
Kostenlos starten →